作者单位：
New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: weiyuancheng2000@163.com.
[1]
New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: lyud12@163.com.
[2]
New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: wjj07032022@163.com.
[3]
New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: bpforacademic@gmail.com.
[4]
Computer Science Department, Emory University, Atlanta, 30322, United States. Electronic address: xu.chenxi@outlook.com.
[5]
New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: yuanst1967@163.com.
[6]
New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: sunli@cpu.edu.cn.
[7]
DOI
10.1016/j.ejphar.2025.177350
PMID
39914786
发布时间
2025-02-12
换一批
换一批
